Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

Related Citations for PubMed (Select 10673829)

1.
2.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
4.

Treatment of attention-deficit/hyperactivity disorder.

Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R.

Evid Rep Technol Assess (Summ). 1999 Nov;(11):i-viii, 1-341.

5.
6.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
7.

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.

Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K.

Am J Psychiatry. 2005 Sep;162(9):1628-36.

PMID:
16135621
8.

Special considerations in diagnosing and treating attention-deficit/hyperactivity disorder.

Wigal SB, Wigal TL.

CNS Spectr. 2007 Jun;12(6 Suppl 9):1-14; quiz 15-6. Review.

PMID:
17545959
9.

Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder.

Jensen P.

J Atten Disord. 2002;6 Suppl 1:S45-56. Review.

PMID:
12685518
10.

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M.

J Neural Transm Suppl. 2007;(72):311-5.

PMID:
17982908
11.

Attention-deficit hyperactivity disorder.

Calis KA, Grothe DR, Elia J.

Clin Pharm. 1990 Aug;9(8):632-42. Review. Erratum in: Clin Pharm 1991 Apr;10(4):261.

PMID:
1974836
12.
13.

Psychosocial treatments for attention-deficit/hyperactivity disorder.

Knight LA, Rooney M, Chronis-Tuscano A.

Curr Psychiatry Rep. 2008 Oct;10(5):412-8. Review.

PMID:
18803915
14.

Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.

Wagner KD.

Psychopharmacol Bull. 2002 Winter;36(1):130-42. Review.

PMID:
12397852
15.

[Attention deficit hyperactivity disorder (ADHD): etiology, diagnosis and treatment].

Buitelaar JK, Kooij JJ.

Ned Tijdschr Geneeskd. 2000 Sep 2;144(36):1716-23. Review. Dutch.

PMID:
10992893
16.

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.

Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S.

Eur Neuropsychopharmacol. 2004 Jan;14(1):11-28. Review.

PMID:
14659983
17.

Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies.

Schachar R, Jadad AR, Gauld M, Boyle M, Booker L, Snider A, Kim M, Cunningham C.

Can J Psychiatry. 2002 May;47(4):337-48.

PMID:
12025432
18.

Attention deficit hyperactivity disorder--a review for family physicians.

Karande S.

Indian J Med Sci. 2005 Dec;59(12):546-55. Review.

19.

Attention-deficit hyperactivity and conduct disorder: comorbidity and implications for treatment.

Abikoff H, Klein RG.

J Consult Clin Psychol. 1992 Dec;60(6):881-92. Review.

PMID:
1360990
20.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk